Cutler Group LP Alkermes Plc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$26.4 - $30.54 $100,320 - $116,052	-3,800 Reduced 40.0%	5,700 $20,000
Q1 2022 Apr 14, 2022	SELL	$23.07 - $27.99 $4,614 - $5,598	-200 Reduced 2.06%	9,500 $17,000
Q4 2020 Jan 21, 2021	BUY	$15.39 - $22.1 $149,283 - $214,370	9,700 New	9,700 $9,000
Q2 2019 Aug 09, 2019	SELL	$21.47 - $37.33 $536,750 - $933,250	-25,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$28.4 - $36.49 $568,000 - $729,800	20,000 Added 400.0%	25,000 $73,000
Q2 2018 Aug 10, 2018	BUY	$40.56 - $51.36 $133,848 - $169,488	3,300 Added 194.12%	5,000 $1,000
Q1 2018 May 11, 2018	BUY	$53.61 - $67.26 $91,137 - $114,342	1,700 New	1,700 $9,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.